Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
Sunday, June 28, 2015 7:02:48 PM
Dymatize, Optimum Nutrition and lately Cellucor and Quest Nutrition seem to be more popular and loved in the market right now than Musclepharm. Their products are straight forward high quality with straight forward marketing messages not as loud and repetitive as Musclepharm. They don't appear selling well because of endorsements and sponsorships, but because of the quality of their products, and their credible message in their marketing.
The protein bars came off strongly for Musclepharm, but signing the Cavaliers to promote them seem kind of a bet. You don't gain much global, nationwide or local market access from sponsoring the Cavaliers, unless they win the NBA Final. The Cavaliers are not the Bulls, the Lakers, the Heat or the Celtics...
IMO, the brand lacks some substance and direction.
I might be wrong. However, the popularity of the brand should be reflected in the quarterly revenues, and they have been declining versus Q1 and Q2 from last year, for 3 straight quarters. Seasonality or not, it's not highly encouraging or comforting.
Possibly the brand has or will gain in popularity going forward and surpass past revenue numbers, we will have to wait and see as quarterly numbers are announced.
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM